CDT Equity Inc. SEC filings CDT
CDT Equity Inc. has 368 filings in SEC EDGAR's recent list, going back to Dec 9, 2021. Its latest annual report, Form ARS, was filed on Aug 11, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (change to shareholder rights, bylaw or fiscal year change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Nov 4, 2026 | — |
| 424B3 | Prospectus | Nov 3, 2026 | — |
| 424B3 | Prospectus | Oct 13, 2026 | — |
| 424B3 | Prospectus | Oct 2, 2026 | — |
| 424B3 | Prospectus | Sep 18, 2026 | — |
| 424B3 | Prospectus | Sep 18, 2026 | — |
| S-1 | Registration statement | Sep 8, 2026 | — |
| 424B3 | Prospectus | May 1, 2026 | — |
| S-3 | Shelf registration | Apr 22, 2026 | — |
| 424B5 | Prospectus supplement | Apr 2, 2026 | — |
| 424B3 | Prospectus | Feb 10, 2026 | — |
| S-8 | Employee stock plan registration | Jan 30, 2026 | — |
| S-3 | Shelf registration | Jan 30, 2026 | — |
| S-8 POS | Filing | Dec 12, 2025 | — |
| 424B3 | Prospectus | Aug 12, 2025 | — |
| S-8 | Employee stock plan registration | Aug 11, 2025 | — |
| S-3 | Shelf registration | Jul 31, 2025 | — |
| S-3 | Shelf registration | Apr 22, 2025 | — |
| 424B5 | Prospectus supplement | Mar 10, 2025 | — |
| 424B5 | Prospectus supplement | Feb 19, 2025 | — |
| 424B3 | Prospectus | Feb 14, 2025 | — |
| 424B5 | Prospectus supplement | Feb 10, 2025 | — |
| S-8 | Employee stock plan registration | Feb 6, 2025 | — |
| 424B5 | Prospectus supplement | Feb 6, 2025 | — |
| S-3 | Shelf registration | Feb 5, 2025 | — |
| 424B5 | Prospectus supplement | Jan 15, 2025 | — |
| 424B3 | Prospectus | Dec 16, 2024 | — |
| 424B3 | Prospectus | Dec 9, 2024 | — |
| S-3 | Shelf registration | Nov 25, 2024 | — |
| 424B5 | Prospectus supplement | Nov 4, 2024 | — |
| 424B3 | Prospectus | Nov 4, 2024 | — |
| S-3 | Shelf registration | Oct 24, 2024 | — |
| 424B3 | Prospectus | Sep 17, 2024 | — |
| S-1/A | Amended registration statement | Sep 13, 2024 | — |
| S-1 | Registration statement | Sep 4, 2024 | — |
| 424B3 | Prospectus | Aug 19, 2024 | — |
| 424B3 | Prospectus | May 16, 2024 | — |
| POS AM | Filing | May 2, 2024 | — |
| S-8 | Employee stock plan registration | Jan 10, 2024 | — |
| 424B3 | Prospectus | Dec 18, 2023 | — |
| S-8 | Employee stock plan registration | Dec 1, 2023 | — |
| S-1/A | Amended registration statement | Dec 1, 2023 | — |
| S-1 | Registration statement | Oct 17, 2023 | — |
| 424B3 | Prospectus | Sep 13, 2023 | — |
| 424B3 | Prospectus | Aug 23, 2023 | — |
| 424B3 | Prospectus | Aug 11, 2023 | — |
| S-4/A | Filing | Aug 8, 2023 | — |
| S-4/A | Filing | Jul 28, 2023 | — |
| S-4/A | Filing | Jul 11, 2023 | — |
| S-4 | Registration for a merger or exchange | May 12, 2023 | — |
| 424B5 | Prospectus supplement | Feb 4, 2022 | — |
| S-1/A | Amended registration statement | Jan 28, 2022 | — |
| S-1 | Registration statement | Jan 6, 2022 | — |
Showing 53 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CDT (Nasdaq), CDTTW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Naples, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1896212
- Former names
- CONDUIT PHARMACEUTICALS INC. (until Aug 7, 2025); Murphy Canyon Acquisition Corp. (until Sep 21, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.